Scientist, In Vivo Pharmacology

Overview\n\n \n\nWe are seeking a highly motivated Scientist, In Vivo Pharmacology to support the development of innovative therapeutics for autoimmune diseases and oncology. The ideal candidate will have strong hands-on experience in preclinical in vivo models and a solid understanding of immunology and translational research.\n\nIn this role, you will design and execute in vivo studies, perform downstream ex vivo analyses, and collaborate cross-functionally (including with CRO partners) to advance drug discovery programs. In vivo models are critical for evaluating therapeutic efficacy, immune modulation, and translational relevance in both autoimmune and tumor settings\n\n \n\nThis position is onsite and will be primarily located in Cambridge, MA. \n\n \n\nKey Responsibilities\n\n \n\n * Design and execute in vivo pharmacology studies in autoimmune and tumor models. \n * Perform in vivo procedures including animal dosing (IV, IP, SC, PO), tumor implantation, disease induction, and tissue collection. \n * Conduct ex vivo analyses from collected tissues, including: Flow cytometry for immune profiling, qPCR for gene expression analysis and cytokine and biomarker assessment \n * Analyze and interpret data (tumor growth, disease scores, immune readouts) and prepare clear study summaries and presentations. \n * Collaborate with internal teams and external CROs to design, execute, and monitor outsourced studies; ensure data quality and timely delivery. \n * Contribute to study design, including model selection, dosing strategies, and endpoint definition. \n * Maintain accurate documentation in compliance with regulatory and ethical standards (e.g., IACUC).\n\n\n\n \n\nQualifications\n\n \n\n * PhD, Masters, Bachelors, in Immunology, Biology, Pharmacology, or a related discipline. \n * PhD 0+, Masters 10+ years, Bachelors 12+ of hands-on experience in in vivo pharmacology within biotech or pharmaceutical settings. \n * Demonstrated expertise in autoimmune disease models and tumor models, including study design, execution, and data interpretation. \n * Proficiency in common in vivo techniques: animal handling and dosing (multiple routes), tumor implantation and measurement, disease scoring in autoimmune models, necropsy and tissue collection.\n * Experience analyzing downstream endpoints such as flow cytometry, cytokine assays, molecular biomarkers, qPCR, and ELISA assays. \n * Demonstrated ability to independently design experiments, troubleshoot, and manage multiple studies simultaneously. \n * Strong organizational skills, attention to detail, and commitment to scientific rigor and reproducibility. \n * Excellent communication and interpersonal skills, with the ability to effectively collaborate across multidisciplinary teams.\n\n\n\n \n\n#LI-JR1\n\nU.S. Pay Range\n\n$110,400.00 - $165,600.00\n\nThe pay range reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on a number of factors including, but not limited to, relevant experience, skills, and education. This role is eligible for an annual short-term incentive award (e.g., bonus or sales incentive) and an annual long-term incentive award (e.g., equity).\n\nAlnylam\u2019s robust Total Rewards package is designed to support your overall health and well-being. We offer comprehensive benefits including medical, dental, and vision coverage, life and disability insurance, a lifestyle reimbursement program, flexible spending and health savings accounts and a 401(k)with a generous company match. Eligible employees enjoy paid time off, wellness days, holidays, and two company-wide recharge breaks. We also offer generous family resources and leave. Our commitment to your well-being reflects our belief that caring for our people fuels the impact we create together.\n\nLearn more about these and additional benefits offered by Alnylam by visiting the Benefits section of the Careers website: https://www.alnylam.com/careers\n\nAbout Alnylam\n\nWe are the leader in RNAi therapeutics \u2013 a revolutionary approach with the potential to transform the lives of people with rare and common diseases. Built on Nobel Prize-winning science, Alnylam has delivered the breakthroughs that made RNAi therapeutics possible and are just at the beginning of what\u2019s possible. Our deep pipeline, late-stage programs, and bold vision reflect our core values: fierce innovation, passion for excellence, purposeful urgency, open culture and commitment to people. We\u0027re proud to be a globally recognized top employer, where an authentic, inclusive culture and breakthrough thinking fuel one another.\n\nAt Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. Qualified applicants will receive consideration for employment without regard to their sex, gender or gender identity, sexual orientation, race, color, ethnicity, national origin, ancestry, citizenship, religion, creed, physical or mental disability, pregnancy status or related conditions, genetic information, veteran or military status, marital or familial status, political affiliation, age, or any other factor protected by federal, state, or local law. Alnylam is an E-Verify Employer.\n